Conference Coverage

Chlamydia infections associated with more than a doubling of ovarian cancer risk

Publish date: March 16, 2018

 

FROM THE AACR ANNUAL MEETING


Neither cohort showed any significant association of ovarian cancer with any of the other antibodies, Dr. Trabert said.

The NCI Intramural Research Program supported the study. Dr. Trabert and her colleagues declared no conflicts of interest.

SOURCE: Trabert et al. Abstract 4942.

Pages

Recommended Reading

New 9-valent HPV vaccine is efficacious, well tolerated
MDedge Dermatology
Contamination prompts voluntary injectables recall
MDedge Dermatology
ASCO: Precision medicine initiatives take wing
MDedge Dermatology
Single HPV vaccine dose appears as effective as full course
MDedge Dermatology
9-valent HPV vaccine equally effective in adolescents, young women
MDedge Dermatology
New cancer cases to reach nearly 2.4 million in 2035 – AACR
MDedge Dermatology
Cancer prevention field riding high into the new year
MDedge Dermatology
Bone marrow transplant cures severe HPV disease in GATA2 immunodeficiency
MDedge Dermatology
Incidence of HPV-associated cancers on the rise
MDedge Dermatology
Telling her she has cancer: A patient-centered approach to breaking bad news
MDedge Dermatology